FdaApplication

BLA 125671

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNovo Nordisk Inc.
application_typeBLA
approval_date2019-02-19

Products (7)

ProductActive ingredientStrengthDosage form
ESPEROCT—3000IUFor Injection
ESPEROCT—500IUFor Injection
ESPEROCT—1000IUFor Injection
ESPEROCT—2000IUFor Injection
ESPEROCT—5000IUFor Injection
ESPEROCT—4000IUFor Injection
ESPEROCT—1500IUFor Injection

7 products